Two questions sit behind everything in this pillar, and they have different answers. Is the material hazardous? — and what will a regulator require of you? The clay minerals themselves have a fairly reassuring toxicology record, but that does not make the compliance work small, and the real workplace hazard is not always the one people expect.
Start with the health data. Nanoclay Toxicity and Worker Exposure is direct about it: the inhalation question is the one that matters, the crystalline silica impurity is the genuine hazard rather than the clay, and there is a specific number you should be asking your supplier for. It also sets out what competent handling looks like in practice.
For day-to-day operations, Nanoclay Safety, Handling and Regulatory Status covers the safety profile, handling procedures and the regional landscape in one place — the orientation piece if you are writing procedures rather than filings.
For the filings themselves, REACH, TSCA and FDA compares the three architectures region by region and gives a practical compliance sequence. The EU has the most nano-specific framework; the US works from inventory listing plus a separate reporting layer; Asia-Pacific generally puts inventory listing first.
Two situations add a layer on top. Nano reporting and labeling matters because there is no single definition of a nanomaterial and the triggers differ by jurisdiction — sometimes for the same product. And food-contact compliance is its own gate, with migration limits, distinct EU and US pathways, and a known set of places the process stalls.